Research Project
Grant-in-Aid for Scientific Research (C)
Few therapeutic strategies have been established for the treatment of chronic kidney diseases (CKD). Therefore, to develop a new class of the drugs is absolutely required for the patients with CKD to avoid the renal replacement therapy. Here, we demonstrated that a serine protease inhibitor significantly reduced the progression of CKD by ameliorating the glomerulosclerosis and by inhibiting the interstitial fibrosis, which suggests that serine proteases are involved in the development of the progression of CKD. In addition, we isolated plasmin as a candidate serine protease involved in the aldosterone induced renal injury.
All 2014 2013 2012 Other
All Journal Article (11 results) (of which Peer Reviewed: 11 results, Acknowledgement Compliant: 1 results, Open Access: 2 results) Presentation (2 results) Remarks (1 results)
Am J Kidney Dis.
Volume: 65 Issue: 3 Pages: 490-493
10.1053/j.ajkd.2014.09.028
Kidney Int.
Volume: 86 Issue: 4 Pages: 845-854
10.1038/ki.2014.114
Nat Commun.
Volume: 11 Issue: 1 Pages: 3428-3428
10.1038/ncomms4428
Clin Exp Nephrol.
Volume: 18 Issue: 3 Pages: 461-468
10.1007/s10157-013-0833-5
Am. J. Physiol. (Renal Physiol.)
Volume: 305 Issue: 2 Pages: F173-F181
10.1152/ajprenal.00586.2012
Hypertens. Res.
Volume: 36 Issue: 6 Pages: 528-533
10.1038/hr.2012.232
10031189657
Hypertension.
Volume: 61(6) Issue: 6 Pages: 1203-10
10.1161/hypertensionaha.111.00572
Nephron Experimental Nephrology
Volume: 122 Issue: 3-4 Pages: 95-102
10.1159/000348660
Volume: 303 Issue: 8 Pages: F1126-F1135
10.1152/ajprenal.00706.2011
Volume: 303 Issue: 7 Pages: F939-F943
10.1152/ajprenal.00705.2011
Life Sci.
Volume: 91 Issue: 25-26 Pages: 1304-1308
10.1016/j.lfs.2012.09.018
http://yamanashi-3nai.com/